Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
- 31 March 2011
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 44 (1), 20-24
- https://doi.org/10.1002/mus.22114
Abstract
Introduction: Recent studies have provided conflicting data regarding the role of dyslipidemia in amyotrophic lateral sclerosis (ALS). The aim of this study was to determine whether cholesterol level are an independent predictor of survival in ALS. Methods: Cholesterol levels were measured in 427 ALS subjects from three clinical trial databases. Results: The LDL/HDL ratio did not decrease over time, despite significant declines in body mass index (BMI), forced vital capacity (FVC), and ALSFRS‐R. After adjusting for BMI, FVC, and age, the lipid ratio was not associated with survival. There was a “U”‐shaped association between BMI and mortality, with the highest survival at 30–35 kg/m2. The adjusted hazard ratio for the linear association between BMI and survival was 0.860 (95% CI 0.80–0.93, P = 0.0001). Conclusions: We found that dyslipidemia is not an independent predictor of survival in ALS. BMI is an independent prognostic factor for survival after adjusting for markers of disease severity. Muscle Nerve, 2011This publication has 23 references indexed in Scilit:
- Energy metabolism in amyotrophic lateral sclerosisThe Lancet Neurology, 2011
- A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALSAmyotrophic Lateral Sclerosis, 2010
- Lower serum lipid levels are related to respiratory impairment in patients with ALSNeurology, 2009
- Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing GroupsPLOS ONE, 2009
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosisNeurology, 2008
- Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosisJournal of Lipid Research, 2007
- Trial of celecoxib in amyotrophic lateral sclerosisAnnals of Neurology, 2006
- Hypermetabolism in ALS: Correlations with Clinical and Paraclinical ParametersNeurodegenerative Diseases, 2005
- Nutritional assessment and survival in ALS patientsAmyotrophic Lateral Sclerosis, 2000
- Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type)Metabolism, 1981